While an earlier study found no association of tumour ST2 expression with CRC patient survival (86), two recent studies showed that CRC patients who have increased tumour IL1RL1 expression and high densities of ST2-positive cells showed reduced overall survival (87, 88), indicating that ST2+ cells may contribute to CRC pathogenesis. This evidence concerns the gene IL1RL1 and colorectal carcinoma.